Significantly more bimatoprost-treated subjects had at least a one-grade improvement in GEA score from baseline to month 4 compared with vehicle in study 1 ( 77.3 vs 17.6 % ; P < 0.001 ) and study 2 ( 88.9 vs 27.8 % ; P < 0.001 ) .